Ticagrelor-Based Dual Antiplatelet Therapy Duration in CABG
Ticagrelor-Based Dual Antiplatelet Therapy Duration in CABG
Not yet recruiting · NCT06981390 · Registry updated 2026-04-24Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Ticagrelor-Based Dual Antiplatelet Therapy Duration in CABG | Arterial Occlusive Diseases, arteriosclerosis disorder, cardiovascular disorder, coronary artery disorder, heart disorder, myocardial ischemia, vascular disorder | Not yet recruiting | Not applicable | 2026-04-24 | NCT06981390 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Kexiang Liu, MD | 1 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| The Second Hospital of Jilin University | Changchun | China | 8 |